Kevin J. Klos - Concepedia

Author

Kevin J. Klos

Mayo Clinic

Also Known As

Andrew McGarry, Jan Kassubek, K Kłoś, K. J. Klos, K. Klos, K.J. Klos, KEVIN KLOS, Kevin J. Klos, Kevin Klos, Maya Katz

Publications

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Florida WinnMed Mayo Clinic in Arizona Jacksonville College

About

Kevin J. Klos is an author at Mayo Clinic specializing in medicine, neurology, and parkinson disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Neurology	9	9	1.8K
3	Neuroscience	4	4	1.3K
4	Social Sciences	2	2	629
5	Pharmacology	1	1	44

Kevin J. Klos

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease Maryellen L. Dodd, Kevin J. Klos, James H. Bower, Archives of Neurology NeuropsychologyPathological GamblingBehavioral AddictionPsychopharmacologyNeuropsychiatry	2005	564
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease Dennis W. Dickson, Hiroshige Fujishiro, Anthony DelleDonne, Acta Neuropathologica Neurodegenerative DiseasesPre-symptomatic Parkinson ’Neurological DisorderParkinson DiseaseMotor Disorder	2008	357
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Kevin J. Klos, James H. Bower, Keith A. Josephs, Parkinsonism & Related Disorders Dopamine Agonist TherapyMultiple System AtrophyDegenerative DiseaseNeuropharmacologyNeurology	2005	281
Early‐onset familial parkinsonism due to <i>POLG</i> mutations Guido Davidzon, Paul Greene, Michelangelo Mancuso, Annals of Neurology	2006	233
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity Keith A. Josephs, J. Eric Ahlskog, Kevin J. Klos, Neurology	2005	230
Incidental Lewy Body Disease and Preclinical Parkinson Disease Anthony DelleDonne, Kevin J. Klos, Hiroshige Fujishiro, Archives of Neurology	2008	196
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial Michael J. Soileau, Jason Aldred, Kumar Budur, The Lancet Neurology Advanced ParkinsonParkinson DiseaseNeurologyMedicineContinuous Subcutaneous Foslevodopa-foscarbidopa	2022	172
Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? Roberta Frigerio, Hiroshige Fujishiro, Tae Beom Ahn, Neurobiology of Aging Alzheimer's DiseaseCorticobasal DegenerationNeuroepidemiologyDementiaPreclinical Stage	2009	169
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease Hiroshige Fujishiro, Roberta Frigerio, Melinda S. Burnett, Movement Disorders	2008	167
α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals Kevin J. Klos, J. Eric Ahlskog, Keith A. Josephs, Neurology	2006	126

Page 1